glutathione structure molecule and mechanism to form Frontiers Glutathione-Mediated Conjugation of Anticancer Drugs:
Description
There are no active IND applications or FDA-registered clinical trials for TB-500
For example, advancing clinical trials of combination therapeutic strategies utilizing EZH2 inhibitors and ferroptosis inducers to validate their synergistic efficacy in cancer treatment, or developing lipid metabolism-based biomarkers e.g., SCD1 expression level for identifying EZH2 inhibitor-sensitive patient populations
These types of reactions often look like small red spots or a mild heat-like rash and usually subside as the body finds its new balance
This includes how people use the compound, its side effects, and how it acts
